Literature DB >> 9013408

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

H Tohgi1, T Abe, M Kimura, M Saheki, S Takahashi.   

Abstract

The acetylcholine (ACh) and choline (Ch) concentrations in the cerebrospinal fluid were investigated in patients with vascular dementia of the Binswanger type (VDBT) or multiple small infarct type (MSID) as compared with patients with Alzheimer-type dementia (ATD). The ACh concentration in patients with ATD was found to be significantly lower than in controls (73%, p < 0.0001), and showed a significant positive correlation with dementia scale scores (rs = 0.63, p < 0.03). The Ch concentration in the CSF of ATD patients was approximately the same as in controls. In VDBT/MSID patients, the ACh concentration was significantly lower than in controls (p < 0.001) also showing a significant positive correlation with dementia scale scores (rs = 0.62, p < 0.02), but was significantly higher than in ATD patients (p < 0.001). Moreover, the Ch concentration in VDBT/MSID patients was significantly higher than in controls (p < 0.001) or ATD patients (p < 0.001). These results suggest that simultaneous determination of ACh and Ch concentrations in CSF may be useful for differentiating VDBT/MSID from ATD and that increasing the ACh level using cholinergic agents may be a beneficial therapeutic strategy for the treatment of ATD as well as VDBT/MSIT, and is worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013408     DOI: 10.1007/BF01271206

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  41 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Effects of middle cerebral artery occlusion on cerebral cortex choline and acetylcholine in rats.

Authors:  O U Scremin; D J Jenden
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

Review 3.  Pathogenetic basis of vascular dementia.

Authors:  A Wallin; K Blennow
Journal:  Alzheimer Dis Assoc Disord       Date:  1991       Impact factor: 2.703

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 5.  Problems in the organization and control of acetylcholine synthesis in brain neurons.

Authors:  S Tucek
Journal:  Prog Biophys Mol Biol       Date:  1984       Impact factor: 3.667

6.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

7.  Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.

Authors:  H Tohgi; M Ueno; T Abe; S Takahashi; Y Nozaki
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

8.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

9.  Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.

Authors:  T D Bird; S Stranahan; S M Sumi; M Raskind
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

10.  Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia.

Authors:  H Tohgi; T Abe; S Takahashi; M Kimura; J Takahashi; T Kikuchi
Journal:  Neurosci Lett       Date:  1992-07-06       Impact factor: 3.046

View more
  32 in total

1.  Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia.

Authors:  Karen E Mate; Karen P Kerr; Dimity Pond; Evan J Williams; John Marley; Peter Disler; Henry Brodaty; Parker J Magin
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 2.  Cognitive impairment in acquired brain injury: a predictor of rehabilitation outcomes and an opportunity for novel interventions.

Authors:  Ellen Whyte; Elizabeth Skidmore; Howard Aizenstein; Joseph Ricker; Meryl Butters
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 3.  Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.

Authors:  Paul Noufi; Rita Khoury; Sajeeka Jeyakumar; George T Grossberg
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

4.  Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway.

Authors:  Shengli Ma; Juwu Chen; Chen Chen; Na Wei; Jingjing Xu; Guohui Yang; Nan Wang; Yu Meng; Jia Ren; Zongchao Xu
Journal:  Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.590

5.  Treatment of Vascular Cognitive Impairment.

Authors:  Aaron Ritter; Jagan A Pillai
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

6.  Homocysteine inhibits butyrylcholinesterase activity in rat serum.

Authors:  Francieli M Stefanello; Alexandra I Zugno; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

Review 7.  Cholinesterase inhibitors and vascular dementia: another string to their bow?

Authors:  Roger Bullock
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

9.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Pharmacodynamic study of FS-0311: a novel highly potent, selective acetylcholinesterase inhibitor.

Authors:  Zhi Fei Wang; Jin Yan; Yan Fu; Xi Can Tang; Song Feng; Xu Chang He; Dong Lu Bai
Journal:  Cell Mol Neurobiol       Date:  2007-09-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.